Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) EPS (Weighted Average and Diluted) (2020 - 2025)

iSpecimen has reported EPS (Weighted Average and Diluted) over the past 6 years, most recently at -$0.74 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 88.22% year-over-year to -$0.74; the TTM value through Dec 2025 reached -$2.35, up 87.27%, while the annual FY2025 figure was -$2.28, 87.03% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.74 at iSpecimen, down from -$0.48 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.08 in Q4 2021 and troughed at -$6.77 in Q4 2023.
  • A 5-year average of -$1.96 and a median of -$0.6 in 2025 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 104.95% in 2021 and later crashed 2720.83% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.08 in 2021, then tumbled by 400.0% to -$0.24 in 2022, then tumbled by 2720.83% to -$6.77 in 2023, then grew by 7.24% to -$6.28 in 2024, then soared by 88.22% to -$0.74 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for ISPC at -$0.74 in Q4 2025, -$0.48 in Q3 2025, and -$0.42 in Q2 2025.